GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (NEOE:BMND) » Definitions » Net Margin %

Biomind Labs (NEOE:BMND) Net Margin % : 0.00% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Biomind Labs Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Biomind Labs's Net Income for the three months ended in Sep. 2023 was C$-0.17 Mil. Biomind Labs's Revenue for the three months ended in Sep. 2023 was C$0.00 Mil. Therefore, Biomind Labs's net margin for the quarter that ended in Sep. 2023 was 0.00%.

The historical rank and industry rank for Biomind Labs's Net Margin % or its related term are showing as below:


NEOE:BMND's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -160.92
* Ranked among companies with meaningful Net Margin % only.

Biomind Labs Net Margin % Historical Data

The historical data trend for Biomind Labs's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomind Labs Net Margin % Chart

Biomind Labs Annual Data
Trend Dec21 Dec22
Net Margin %
- -

Biomind Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biomind Labs's Net Margin %

For the Biotechnology subindustry, Biomind Labs's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomind Labs's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomind Labs's Net Margin % distribution charts can be found below:

* The bar in red indicates where Biomind Labs's Net Margin % falls into.



Biomind Labs Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Biomind Labs's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-4.056/0
= %

Biomind Labs's Net Margin for the quarter that ended in Sep. 2023 is calculated as

Net Margin=Net Income (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-0.17/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomind Labs  (NEOE:BMND) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Biomind Labs Net Margin % Related Terms

Thank you for viewing the detailed overview of Biomind Labs's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomind Labs (NEOE:BMND) Business Description

Traded in Other Exchanges
Address
Camino Saravia s/n, Pando Science and Technology Park, Pando Canelones, Canelones, URY, CP 91.000
Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.

Biomind Labs (NEOE:BMND) Headlines

No Headlines